Escalon Medical Corp. (ESMC) Net margin 2017–2026
Escalon Medical Corp. (ESMC) net profit margin by fiscal year — reported net income divided by reported revenue.
31.5%FY2026 · since FY2017: -6.5% → 31.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 31.5% | +30.6 pp |
| FY2025 | 0.9% | +1.9 pp |
| FY2024 | -1.0% | -4.8 pp |
| FY2023 | 3.8% | +3.6 pp |
| FY2022 | 0.2% | +0.7 pp |
| FY2021 | -0.5% | +6.4 pp |
| FY2020 | -6.9% | -4.3 pp |
| FY2019 | -2.6% | -7.7 pp |
| FY2018 | 5.1% | +11.6 pp |
| FY2017 | -6.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ESMC financial trends
ESMC RevenueESMC Net incomeESMC Gross profitESMC Gross marginESMC Operating incomeESMC Operating marginESMC Operating cash flowESMC Free cash flowESMC Capital expendituresESMC Return on equityESMC Stock buybacksESMC Dividends paidESMC Total assetsESMC Total liabilitiesESMC Shareholders’ equityESMC overview →